Business Report :
Renata Limited – a manufacturer of pharmaceuticals and animal health products – has reported a 21.4% growth in profit and while its revenue grew by 9% in the January to March quarter of the current fiscal year over the same time of the previous fiscal year.
During the Q3, it logged Tk72.62 crore profit, and Tk921.844 crore revenue, according to its consolidated interim financial statements for the nine months.
However, its revenue grew by 14% to Tk2781.46 crore but its profit fell by 4% to Tk258.07 crore.
Despite the decline in profit, company officials said its nine months profit surpassed its last year annual profit. In the last FY23, it made a profit of Tk233 crore.
While its half-yearly financials report showed, it had reported a 21.76% revenue growth in the second quarter of fiscal year 2023-24, and its profit increased by 1.49% as cost of sales including raw material costs, utility cost increased significantly.